Concepedia

S V Otton

SV

Statistics

Publications

26

Citations

2K

H-Index

23

Active since

1980

Affiliations

University of Toronto(Current)

Addiction Research Foundation

Odense University Hospital

University of Southern Denmark

Royal Hallamshire Hospital

S V Otton is an author at University of Toronto specializing in medicine, pharmacology, and metabolomics.

Top concepts

Publications per year

1980–1999

26

Publications

26

Inhibition by fluoxetine of cytochrome P450 2D6 activity

S V Otton, Dafang Wu, Russell T. Joffe et al. · Clinical Pharmacology & Therapeutics · 1993 · 260 citations

Venlafaxine oxidation<i>in vitro</i>is catalysed by CYP2D6

S V Otton, S. Ball, Siu Wah Cheung et al. · British Journal of Clinical Pharmacology · 1996 · 227 citations

Competitive inhibition of sparteine oxidation in human liver by β-adrenoceptor antagonists and other cardiovascular drugs

S V Otton, T. Inaba, W. Kalow · Life Sciences · 1984 · 187 citations

, , +11

CYP2D6 phenotype determines the metabolic conversion of hydrocodone to hydromorphone

S V Otton, Mordecai Schadel, Siu Wah Cheung et al. · Clinical Pharmacology & Therapeutics · 1993 · 181 citations

Use of quinidine inhibition to define the role of the sparteine/debrisoquine cytochrome P450 in metoprolol oxidation by human liver microsomes.

S V Otton, H.K. Crewe, M. S. Lennard et al. · Journal of Pharmacology and Experimental Therapeutics · 1988 · 162 citations

1–5 of 26